Early udder inflammation in dairy cows treated by a homeopathic medicine (Dolisovet^®): a prospective observational pilot study

Background: Mammary inflammation in dairy cows is a widespread problem in dairy farming resulting in significant economic and welfare concerns. Dolisovet^® (Belladonna 1dH, Calendula MT, Echinacea 1dH, Dulcamara 1cH) a homeopathic medicine, licensed in France and indicated for the restoration of mammary function in cows is presented as a 10 g tube of ointment for intramammary use.

Method: A prospective, uncontrolled, observational pilot study involving the collection and analysis of data from 31 udder quarters identified as being inflamed by an automated milking system (AMS) was conducted to evaluate the effect of Dolisovet^® on selected parameters of mammary inflammation. Inflamed quarters were identified when milk quality started to deteriorate, via an alert generated by the AMS, on the basis of electrical conductivity (EC). Milk yield and EC were retrieved five to seven days prior to the AMS alert, on the day of and for the following seven days. Dolisovet^® was administered twice daily for two consecutive days, commencing on the day of the AMS alert.

Results: A significant reduction in EC was observed 4–7 days following the first treatment. An increase in milk yield was also observed following the first treatment.

Conclusion: Dolisovet^® may have a beneficial therapeutic effect in the early stages of udder inflammation and for restoring udder health and function. This medicine may be an effective first line treatment for sub-clinical bovine mastitis, reducing the need for antibiotics. Randomised, controlled studies should be undertaken to further investigate this possibility.

Keywords

Homeopathy - Prospective study - Dairy cattle - Mastitis - Udder inflammation - Conductivity - Milk production

• References

• 1 Fourichon C., Seegers H., Bareille N., Beaudeau F. Estimation des pertes et de l'impact économique consécutifs aux principaux troubles de santé en élevage bovin laitier. Renc Rech Ruminants 2001; 8: 137-143.
• 2 Marguet M. Affections de la mammelle. Manuel pratique. Maladie des bovins. 4th ed. Paris: Institut de l'élevage; 2008. Editions France Agricole, pp. 522–531.
• 3 Seegers H., Hortet P. Calculated milk production losses associated with elevated somatic cell counts in dairy cows: review and critical discussion. Vet Res 1998; 29: 497-510.
• 4 Fourichon C., Seegers H., Beaudeau F., Verfaille L., Bareille N. Health-control costs in dairy farming systems in western France. Livest Prod Sci 2001; 68: 141-156.
• 5 Seegers H., Fourichon C., Beaudeau F. Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res 2003; 34: 475-491.
• 6 Hendriksen R.S., Mevius D.J., Schroeter A. et al. Prevalence of antimicrobial resistance among bacterial pathogens isolated from cattle in different European countries: 2002–2004. Acta Vet Scand 2008; 50: 28-38.
• 7 Journel C., Alexandre B. Effet de l'injecteur homéopathique BONAMAM INTRAMAMMAIRE sur les concentrations de cellules somatiques du lait. Journées Nationales GTV – Nantes 2009: 689-695.
• 8 Guinane C.M., Sturdevant D.E., Herron-Olson L. et al. Pathogenomic analysis of the common bovine Staphylococcus aureus clone (ET3): emergence of a virulent subtype with potential risk to public health. J Infect Dis 2008; 197: 205-213.
• 9 Günaydın B., Aslantaş O., Demir C. Detection of superantigenic toxin genes in Staphylococcus aureus strains from subclinical bovine mastitis. Trop Anim Health Prod 2011; 43: 1633-1637.
• 10 2011/2848(RSP): European Parliament resolution of 27 October 2011 on the public health threat of antimicrobial resistance. URL: http://www.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&reference=2011/2848(RSP) (accessed January 2013).
• 11 Le plan national de réduction des risques d'antibiorésistance en medecine vétérinaire, 2011, URL: http://agriculture.gouv.fr/Resistance-aux-antibiotiques (accessed January 2013).
• 12 Steeneveld W., Van Der Gaag L.C., Ouweltjes W., Mollenhorst H., Hogeveen H. Discriminating between true-positives and false-positives clinical mastitis alerts from automatic milking systems. J Dairy Sci 2010; 93: 2559-2568.
• 13 Emanuelson U., Olsson T., Holmberg O. et al. Comparison of some screening tests for detecting mastitis. J Dairy Sci 1987; 70: 880-887.
• 14 Nielen M., Deluyker H., Schukken Y.H., Brand A. Electrical conductivity of milk: measurement, modifiers, and meta analysis of mastitis detection performance. J Dairy Sci 1992; 75: 606-614.
• 15 Biggadike H.J., Ohnstad I., Laven R.A., Hillerton J.E. Evaluation of measurements of the conductivity of quarter milk samples for the early diagnosis of mastitis. Vet Rec 2002; 150: 655-658.
• 16 Mansell P.D., Seguya A. The use of a hand-held conductivity meter for the diagnosis of subclinical mastitis in dairy cows during late lactation. N Z Vet J 2003; 51: 21-25.
• 17 Norberg E., Hogeveen H., Korsgaard I.R., Friggens N.C., Sloth K.H., Løvendahl P. Electrical conductivity of milk: ability to predict mastitis status. J Dairy Sci 2004; 87: 1099-1107.
• 18 Sun Z., Samarasinghe S., Jago J. Detection of mastitis and its stage of progression by automatic milking systems using artificial neural networks. J Dairy Res 2010; 77: 168-175.
• 19 Fernando R.S., Rindsig R.B., Spahr S.L. Electrical conductivity of milk for detection of mastitis. J Dairy Sci 1982; 65: 659-664.
• 20 Fosgate G.T., Petzer I.M., Karzis J. Sensitivity and specificity of a hand-held milk electrical conductivity meter compared to the California mastitis test for mastitis in dairy cattle. Press Vet J Sep 2012; 13.
• 21 Billon P., Pommies D. Robotic milking 15 years after its first implementation on commercial farms. Renc Rech Ruminants 2006; 13: 143-150.